Viviane Tabar: Featured News

Lorenz Studer and Viviane Tabar
Upcoming Clinical Trial Will Test New Cell Therapy for Parkinson’s Disease in Humans
Study will be the first clinical trial testing an investigational stem cell therapy aimed at restoring lost brain cells called neurons in people with advanced Parkinson’s disease (PD).
In the Lab
Fibrous extensions of a nerve cell (red) and an oligodendrocyte (green) growing on top of the nerve cell
Can Stem Cells Be Taught to Repair a Radiation-Damaged Brain?
In a recent study, Memorial Sloan Kettering scientists used stem-cell engineering to repair brain injuries in rats. The results raise hope for future therapies that could prevent or fix nerve damage in cancer patients who need brain radiation.
In the Lab
Pictured: Viviane Tabar
Investigators Use Stem Cells to Study Rare Pediatric Brain Tumors
Investigators have created the first-ever genetically engineered model of cancer made from human embryonic stem cells in culture.
Pictured: Lorenz Studer and Viviane Tabar
Physician-Scientists Viviane Tabar and Lorenz Studer Elected to the American Society for Clinical Investigation
Two Memorial Sloan Kettering physician-scientists were elected to one of the nation’s oldest and most respected medical honor societies.
Pictured: Neural stem cells
Starr Foundation Renews Gifts for Cancer Consortium and Stem Cell Research Initiative
Research at Memorial Sloan Kettering will benefit from renewed support for The Starr Cancer Consortium and the Tri-Institutional Stem Cell Initiative totaling $105 million.
Pictured: Sensory Neurons
New Center for Stem Cell Biology Launched
A new center at the Sloan Kettering Institute is exploring the potential of embryonic stem cells and human adult cells to produce regenerative treatments and provide insights into cancer.
Viviane S. Tabar
Memorial Sloan Kettering Researchers Show Brain Tumors Make Their Own Blood Vessels from Stem Cells
Memorial Sloan Kettering Cancer Center researchers have published new findings that may help explain why brain tumors called glioblastomas are so resistant to treatment.
Investigators Pioneer a Cell-Based System for Modeling Disease and Treatment
Memorial Sloan Kettering researchers have engineered stem cells from patients with familial dysautonomia, a rare genetic disorder, and used them to explore the causes of the disease and to test drugs that might be effective against it.
Therapeutic Cloning Treats Parkinson's Disease in Mice
Research led by investigators at Memorial Sloan Kettering Cancer Center has shown that therapeutic cloning, also known as somatic-cell nuclear transfer (SCNT), can be used to treat Parkinson's disease in mice.